Z-1008-2023 Class II Ongoing

Recalled by Meridian Bioscience Inc — Cincinnati, OH

FDA device recall Z-1008-2023 was initiated by Meridian Bioscience Inc on Dec 15, 2022 and is designated Class II. Reason for recall: Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2 The recall status is ongoing. Affected quantity: 92 kits.

Recall details

Product Type
Devices
Report Date
Feb 1, 2023
Initiation Date
Dec 15, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
92 kits

Product description

Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700

Reason for recall

Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2

Distribution pattern

US Nationwide distribution in the states of AZ, CA, IN, KS, KY, LA, MI, MN, NC, NY, OR, TX.

Code information

UDI: N/A Lot Numbers 410700P019, 410700P020, 410700P021, 410700P022, 410700P023, 410700P024, 410700P027

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1008-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1008-2023. Report a data issue: hello@regdatalab.com.